Prolonged bacterial exposure to minocycline/rifampicin-impregnated vascular catheters does not affect antimicrobial activity of catheters

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 1, 2007, Pages 148-151

  Aslam, Saima ^a,b   Darouiche, Rabih O ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antimicrobial resistance; MIC; Minocycline rifampicin impregnated catheters

Indexed keywords

LINEZOLID; METICILLIN; MINOCYCLINE; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; CONTROLLED STUDY; ENTEROCOCCUS; EXPOSURE; HUMAN; IN VITRO STUDY; INTRAVASCULAR CATHETER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; DRUG RESISTANCE, BACTERIAL; EQUIPMENT CONTAMINATION; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE COCCI; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; RIFAMPIN; TIME FACTORS;

EID: 34447567078     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm173     Document Type: Article

References (11)

1. O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51: 1-29.
2. Raad I, Darouiche R, Dupuis J et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997; 127: 267-74.
3. Darouiche RO, Raad II, Heard SO et al. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999; 340: 1-8.
4. Hanna HA, Raad II, Hackett B et al. Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients. Chest 2003; 124: 1030-8.
5. Chatzinikolaou I, Finkel K, Hanna H et al. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: A prospective, randomized study. Am J Med 2003; 115 352-7.
6. Shorr AF, Humphreys CW, Helman DL. New choices for central venous catheters: Potential financial implications. Chest 2003; 124 275-84.
7. Sherertz RJ, Carruth WA, Hampton AA et al. Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J Infect Dis 1993; 167: 98-106.
8. Tambe SM, Sampath L, Modak SM. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 2001; 47: 589-98.
9. Sampath LA, Tambe SM, Modak SM. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 2001; 22: 640-6.
10. Munson EL, Heard SO, Doem GV. In vitro exposure of bacteria to antimicrobial impregnated-central venous catheters does not directly lead to the emergence of antimicrobial resistance. Chest 2004; 126: 1628-35.
11. Chatzinikolaou I, Hanna H, Graviss L et al. Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: Efficacy and low dsk of developing staphylococcal resistance. Infect Control Hosp Epidemiol 2003; 24: 961-3.